Trial intelligence / Profile preview

Vinblastine and Methotrexate in Children With Multivessel Pulmonary Vein Stenosis

NCT00215046Phase 2Completed

Sponsor
Boston Children's Hospital
Start
Mar 2000
Primary completion
Oct 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of vinblastine and methotrexate in pulmonary vein stenosis (PVS), sponsored by Boston Children's Hospital. Primary endpoint: Patient status one year after the start of treatment at 1 year. Started Mar 2000; status: completed.

02

Drugs

vinblastinemethotrexate
03

Conditions

pulmonary vein stenosis (PVS)

Beyond the preview

Go deeper on NCT00215046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00215046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call